JAMP METHIMAZOLE
JAMP METHIMAZOLE
Approved
DIN Number
02490625
Drug Class
Human
Market Date
Aug 21, 2020
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02490625
AIG Number0104552001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
H03BB02 THIAMAZOLE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:36.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
METHIMAZOLEActive
Strength: 5 MG
Monograph: METHIMAZOLE